Bion Occipital Nerve Stimulation (ONS) Compassionate Use Study

This study has been completed.
Sponsor:
Information provided by:
Boston Scientific Corporation
ClinicalTrials.gov Identifier:
NCT01050959
First received: January 14, 2010
Last updated: April 25, 2011
Last verified: April 2011

January 14, 2010
April 25, 2011
January 2010
April 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01050959 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Bion Occipital Nerve Stimulation (ONS) Compassionate Use Study
Compassionate Use Study of the Bion for Occipital Nerve Stimulation for Treatment of Chronic Headaches

The purpose of this compassionate use study is to provide clinical and technical support of the Bion® microstimulator system to the subjects who have decided to keep the system for relief of headache symptoms that have not responded to medical treatment. These study subjects were enrolled and implanted with the Bion® system during a previous clinical investigation of the Bion® for occipital nerve stimulation (ONS) in the United States.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Subjects who were enrolled and implanted with the Bion® system during a prior feasibility clinical investigation of the device for occipital nerve stimulation (ONS) in the United States.

Chronic, Medically Refractory Headache
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
11
April 2011
April 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subject participated in a prior clinical feasibility study of the Bion for occipital nerve stimulation in the treatment of chronic headaches (IDE G030225) and remained implanted with the Bion system.
  • Subject elects to enroll in this compassionate use study and provides written informed consent.
  • Subject understands the type and duration of clinical, technical or product support provided in the study.
  • Subject is willing to comply with protocol-required activities.

Exclusion Criteria:

  • Subject is currently participating or intends to participate in another investigational drug or device clinical trial for chronic headaches during the study period.
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01050959
A4005, G030225/S022
No
Ann Masuda, Boston Scientific Corporation
Boston Scientific Corporation
Not Provided
Study Director: Blessie Concepcion Boston Scientific Corporation
Boston Scientific Corporation
April 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP